Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 IL17F [1] Th17 cell differentiation D11550 Bimekizumab [3] 46, 97, 271
2 MAPK14 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
3 MAPK14 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
4 MTOR [4] Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D00753 Sirolimus [40] 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331
5 MTOR [4] Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D02714 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277
6 MTOR [4] Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D06068 Temsirolimus [1] 13
7 IFNG [4] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D04242 Fontolizumab [1] 46
8 IFNG [4] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D11120 Emapalumab [3] 49, 65, 107
9 IFNGR1 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326
10 IFNGR2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326
11 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
12 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D06635 Rilonacept [4] 51, 106, 107, 266
13 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09315 Canakinumab [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
14 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09911 Gevokizumab [4] 41, 50, 56, 269
15 IL1R1 [1] Th17 cell differentiation D02934 Anakinra [18] 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299
16 IL2RA [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin [6] 2, 35, 49, 65, 96, 97
17 IL2RA [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03058 Basiliximab [6] 2, 50, 66, 97, 222, 228
18 IL2RA [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03639 Daclizumab [8] 13, 56, 60, 65, 97, 107, 283, 284
19 IL2RB [3] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation, Transcriptional misregulation in cancer D00748 Aldesleukin [6] 2, 35, 49, 65, 96, 97
20 IL2RG [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin [6] 2, 35, 49, 65, 96, 97
21 IL4 [1] Th17 cell differentiation D03117 Binetrakin [1] 46
22 IL4R [1] Th17 cell differentiation D10354 Dupilumab [5] 51, 97, 98, 160, 162
23 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
24 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D08976 Pomalidomide [5] 28, 51, 85, 227, 331
25 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D09669 Siltuximab [2] 28, 331
26 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D10080 Sirukumab [2] 41, 46
27 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D12487 Olokizumab [2] 46, 96
28 IL6R [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D02596 Tocilizumab [21] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
29 IL6R [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D10161 Sarilumab [5] 41, 46, 84, 107, 271
30 IL6R [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D11079 Satralizumab [3] 11, 13, 86
31 IL17A [1] Th17 cell differentiation D09967 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271
32 IL17A [1] Th17 cell differentiation D10071 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271
33 IL17A [1] Th17 cell differentiation D11127 Tibulizumab [1] 53
34 IL17A [1] Th17 cell differentiation D11550 Bimekizumab [3] 46, 97, 271
35 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib [3] 60, 65, 228
36 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
37 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10308 Baricitinib [13] 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
38 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10653 Peficitinib [1] 46
39 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10871 Filgotinib [6] 46, 53, 96, 97, 222, 271
40 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10944 Itacitinib [4] 46, 51, 97, 228
41 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10994 Upadacitinib [8] 40, 41, 46, 49, 96, 97, 107, 271
42 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D11400 Abrocitinib [1] 84
43 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09959 Ruxolitinib [3] 60, 65, 228
44 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
45 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10308 Baricitinib [13] 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
46 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10653 Peficitinib [1] 46
47 JAK3 [2] Th17 cell differentiation, Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
48 JAK3 [2] Th17 cell differentiation, Viral carcinogenesis D10653 Peficitinib [1] 46
49 LCK [2] Th17 cell differentiation, Yersinia infection D03658 Dasatinib [2] 51, 85
50 LCK [2] Th17 cell differentiation, Yersinia infection D06414 Dasatinib [2] 51, 85
51 NFKB1 [8] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D01146 Iguratimod [5] 46, 51, 53, 271, 300
52 IL22 [1] Th17 cell differentiation D11953 Efmarodocokin alfa [2] 96, 97
53 IL23A [2] Th17 cell differentiation, Tuberculosis D09214 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
54 IL23A [2] Th17 cell differentiation, Tuberculosis D10400 Tildrakizumab [2] 162, 271
55 IL23A [2] Th17 cell differentiation, Tuberculosis D10438 Guselkumab [5] 37, 41, 51, 96, 97
56 IL23A [2] Th17 cell differentiation, Tuberculosis D10912 Brazikumab [2] 96, 97
57 IL23A [2] Th17 cell differentiation, Tuberculosis D11052 Risankizumab [4] 37, 96, 97, 271
58 IL23A [2] Th17 cell differentiation, Tuberculosis D11123 Mirikizumab [3] 37, 96, 97
59 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
60 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
61 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
62 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
63 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [2] 49, 222
64 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
65 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
66 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
67 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
68 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [2] 49, 222
69 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
70 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
71 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
72 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
73 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [2] 49, 222
74 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
75 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
76 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
77 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
78 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [2] 49, 222
79 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
80 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
81 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
82 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
83 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [2] 49, 222
84 PRKCQ [2] Vascular smooth muscle contraction, Th17 cell differentiation D09671 Sotrastaurin [1] 97
85 MAPK11 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
86 MAPK11 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
87 MAPK13 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
88 MAPK13 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
89 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D00094 Tretinoin [6] 2, 62, 63, 75, 94, 231
90 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D00348 Isotretinoin [4] 36, 39, 159, 160
91 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D01418 Tamibarotene [2] 26, 96
92 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D02754 Acitretin [1] 37
93 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D02815 Alitretinoin [1] 49
94 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D04162 Fenretinide [1] 299
95 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D06543 Vitamin A [3] 13, 53, 90
96 RELA [8] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D12181 Edasalonexent [1] 113
97 RXRA [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
98 RXRA [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
99 RXRA [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
100 RXRB [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
101 RXRB [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
102 RXRB [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
103 RXRG [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
104 RXRG [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
105 RXRG [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
106 MAPK12 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
107 MAPK12 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
108 TGFB1 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09620 Fresolimumab [3] 51, 85, 222
109 TYK2 [2] Th17 cell differentiation, Toxoplasmosis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
110 TYK2 [2] Th17 cell differentiation, Toxoplasmosis D11817 Deucravacitinib [3] 49, 96, 97
111 CD3D [1] Th17 cell differentiation D06314 Visilizumab [2] 96, 97
112 CD3D [1] Th17 cell differentiation D08959 Otelixizumab [1] 46
113 CD3E [1] Th17 cell differentiation D06314 Visilizumab [2] 96, 97
114 CD3E [1] Th17 cell differentiation D08959 Otelixizumab [1] 46
115 CD3E [1] Th17 cell differentiation D11463 Mosunetuzumab [1] 49
116 CD3G [1] Th17 cell differentiation D06314 Visilizumab [2] 96, 97
117 CD3G [1] Th17 cell differentiation D08959 Otelixizumab [1] 46
118 CD4 [4] Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Th17 cell differentiation, Yersinia infection D06356 Zanolimumab [1] 46